Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Sun Pharma to acquire Organon for $14.00 per share

PRIVATESep 12, 2026•about 2 hours ago

Acquiring Company

Sun Pharmaceutical Industries Ltd

Acquired Company

Organon &

MumbaiJersey CityBiotechnologyHealth CareBiotechnologyHealth CareMedical

Description

Sun Pharmaceutical Industries Ltd. has entered into an agreement to acquire Organon & Co. for $14.00 per share in cash. The deal, which was signed in April and approved by shareholders in July, aims to enhance Sun Pharma's presence in the pharmaceutical market. This acquisition will enable Sun Pharma to expand its portfolio and strengthen its market position significantly.

Company Information

Company

Sun Pharmaceutical Industries Ltd

Location

Mumbai, Maharashtra, India

About

Sun Pharmaceutical Industries Ltd. is a multinational pharmaceutical company headquartered in Mumbai, India. It manufactures and markets a wide range of pharmaceutical products, including branded generics, specialty products, and active pharmaceutical ingredients (APIs), globally.

Don't miss Sun Pharmaceutical Industries Ltd's next move

Get an email the moment Sun Pharmaceutical Industries Ltd makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Usha
Likely contact at this company
••••••••@••••••••

See Usha's verified email →

Jeremy
Likely contact at this company
••••••••@••••••••

See Jeremy's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Sun Pharmaceutical Industries Ltd's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Organon &?

Organon & was acquired by Sun Pharmaceutical Industries Ltd, based in Mumbai. The deal was reported on September 12, 2026. Sun Pharmaceutical Industries Ltd. is a multinational pharmaceutical company headquartered in Mumbai, India. Sun Pharmaceutical Industries Ltd is privately held and operates in Biotechnology.

When did Sun Pharmaceutical Industries Ltd acquire Organon &?

Sun Pharmaceutical Industries Ltd's acquisition of Organon & was reported on September 12, 2026. Sun Pharmaceutical Industries Ltd. has entered into an agreement to acquire Organon & Co. for $14.00 per share in cash. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Organon & do?

Organon is a healthcare company focused on women's health. The company aims to deliver innovative solutions to meet the needs of women. It emphasizes gender equality and women's health issues. Organon is committed to sustainable practices in healthcare. It is publicly traded (OGN), operating in Biotechnology, and is based in Jersey City.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.